Summary: Absci Corporation’s stock has rebounded due to new collaborations, but skepticism about AI’s impact
Summary: Absci’s differentiated drug discovery platform could create significant shareholder value long term. The company
Summary: Absci Corporation’s initiation of a phase 1 study using ABS-101 for the treatment of
Summary: Absci Corporation uses IDCP technology to quickly produce high-quality drug candidates in as little
Summary: Absci Corporation, an AI-driven drug discovery company, has seen its share price plummet after
Summary: Absci combines generative AI with scalable wet lab technologies to improve antibody discovery, with
Summary: Absci, a Vancouver-based drug discovery company that IPOd in July last year, has seen
Summary: Absci, a synthetic biology company whose platform technology aids in the drug discovery process,
Summary: AbSci has filed to raise $200 million in a U.S. IPO. The firm is